Publications by authors named "Steve V Edelman"

Claim this Profile
R
Risk of new-onset type 1 diabetes in individuals with celiac disease and thyroid disease-An observational study.
Steve V Edelman, Daniel Agardh, Nancy Cui, Lichen Hao, Mattias Wieloch

Diabetes Obes Metab· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head-to-head randomized controlled InRange trial.
Tadej Battelino, Thomas Danne, Steve V Edelman, Pratik Choudhary, Eric Renard

Diabetes Obes Metab· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reference Guide for Integrating Continuous Glucose Monitoring Into Clinical Practice.
Davida F Kruger, Steve V Edelman, Deborah A Hinnen, Christopher G Parkin

Diabetes Educ· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment: Glucagon-Like Peptide-1 Receptor Agonists.
Steve V Edelman

J Fam Pract· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to comment on Edelman et al. AUTONOMY: the first randomized trial comparing two patient-driven approaches to initiate and titrate prandial insulin lispro in type 2 diabetes. Diabetes Care 2014;37:2132-2140.
Steve V Edelman, Rong Liu, Jennal Johnson, Leonard C Glass

Diabetes Care· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AUTONOMY: the first randomized trial comparing two patient-driven approaches to initiate and titrate prandial insulin lispro in type 2 diabetes.
Steve V Edelman, Rong Liu, Jennal Johnson, Leonard C Glass

Diabetes Care· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is pramlintide a safe and effective adjunct therapy for patients with type 1 diabetes?
Steve V Edelman, Satish Garg, Orville G Kolterman

Nat Clin Pract Endocrinol Metab· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis